Chronic Heart Failure
Cardiovascular·MeSH: Inflammation
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
11 drugs in development·10 companies·5 clinical trials
Drug Pipeline by Phase
Approved(2)
Phase 3(4)
Phase 2(1)
Phase 1(1)
| Drug | Company |
|---|---|
| myocell sdf-1 | U.S. Stem Cell, Inc. (USRM) |
Unknown(2)
Phase 4(1)
| Drug | Company |
|---|---|
| ferinject | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Heart Failure?
BioSniper tracks 11 drugs in development for Chronic Heart Failure across 10 companies.
How many clinical trials target Chronic Heart Failure?
There are 5 clinical trials targeting Chronic Heart Failure tracked by BioSniper.
What is the prevalence of Chronic Heart Failure?
The estimated prevalence of Chronic Heart Failure is approximately 1800.0 per 100,000 population.
Deep-dive into Chronic Heart Failure
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis